Widespread cortical thinning characterizes patients with MS with mild cognitive impairment
- PMID: 20101038
- DOI: 10.1212/WNL.0b013e3181cbcd03
Widespread cortical thinning characterizes patients with MS with mild cognitive impairment
Abstract
Background: Although cognitive dysfunction affects a relevant portion of patients with multiple sclerosis (MS), its pathologic substrate has not been clarified and it does not seem entirely explained by white matter changes.
Methods: A total of 100 consecutive patients with relapsing remitting MS (RRMS) and 42 normal controls (NC) were enrolled in the study. Cognitive performance was assessed by Rao's Brief Repeatable Battery of Neuropsychological Tests (BRB). Regional cortical thickness (CTh) was evaluated by Freesurfer.
Results: Thirty-one patients with RRMS failed 1 or 2 tests of BRB and were considered to have a mild cognitive impairment (mCI-RRMS), while 8 patients failed at least 3 tests and were classified as markedly impaired (sCI-RRMS). The mean CTh of mCI-RRMS and sCI-RRMS group was significantly lower than in NC (p < 0.001) and cognitively normal patients with RRMS (CN-RRMS) (p < 0.001). The regional analysis revealed significant cortical thinning in frontal and temporal regions (frontotemporal thinning) of CN-RRMS compared to NC, while a widespread pattern of cortical thinning was observed in mCI-RRMS and in sCI-RRMS compared to both CN-RRMS and NC. A correlation was observed between cognitive score (CS) and the mean CTh (r = -0.69, p < 0.001) and between CS and CTh of almost all the cortical areas analyzed (r value between -0.20 and -0.65, p < 0.01). A correlation was found between T2-WM-LV and mean CTh (r = -0.31, p = 0.004) or CS (r = 0.21, p = 0.031). The multivariate analysis confirmed a widespread cortical thinning as the best predictor of cognitive impairment.
Conclusions: A widespread pattern of cortical thinning characterizes patients with cognitive dysfunction, suggesting such dysfunction as expression of a more aggressive and widespread cortical pathology.
Similar articles
-
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment.J Neurol Sci. 2006 Jun 15;245(1-2):195-9. doi: 10.1016/j.jns.2005.07.019. Epub 2006 Apr 24. J Neurol Sci. 2006. PMID: 16631794
-
Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.Brain Res. 2007 Sep 5;1167:71-9. doi: 10.1016/j.brainres.2007.06.023. Epub 2007 Jun 21. Brain Res. 2007. PMID: 17689504
-
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.Mult Scler. 2009 Jul;15(7):779-88. doi: 10.1177/1352458509105544. Mult Scler. 2009. PMID: 19542262
-
Cortical pathology and cognitive impairment in multiple sclerosis.Expert Rev Neurother. 2011 Mar;11(3):425-32. doi: 10.1586/ern.10.155. Expert Rev Neurother. 2011. PMID: 21375447 Review.
-
Cortical lesions and cognitive impairment in multiple sclerosis.Neurol Sci. 2010 Nov;31(Suppl 2):S235-7. doi: 10.1007/s10072-010-0368-4. Neurol Sci. 2010. PMID: 20635113 Review.
Cited by
-
Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis.J Neurol. 2017 Mar;264(3):482-493. doi: 10.1007/s00415-016-8368-9. Epub 2016 Dec 27. J Neurol. 2017. PMID: 28028623
-
The relevance of cortical lesions in patients with multiple sclerosis.BMC Neurol. 2016 Oct 21;16(1):204. doi: 10.1186/s12883-016-0718-9. BMC Neurol. 2016. PMID: 27769199 Free PMC article.
-
Gray matters in multiple sclerosis: cognitive impairment and structural MRI.Mult Scler Int. 2014;2014:609694. doi: 10.1155/2014/609694. Epub 2014 Jan 22. Mult Scler Int. 2014. PMID: 24587905 Free PMC article. Review.
-
Assessment of the diagnostic accuracy of double inversion recovery sequence compared with FLAIR and T2W_TSE in detection of cerebral multiple sclerosis lesions.Electron Physician. 2017 Apr 25;9(4):4162-4170. doi: 10.19082/4162. eCollection 2017 Apr. Electron Physician. 2017. PMID: 28607651 Free PMC article.
-
Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings.PLoS One. 2015 Jul 6;10(7):e0131803. doi: 10.1371/journal.pone.0131803. eCollection 2015. PLoS One. 2015. PMID: 26148120 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources